These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10309192)

  • 21. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive therapeutic interchange program in a community hospital.
    Oh T; Franko TG
    Am J Hosp Pharm; 1991 Jul; 48(7):1471-7. PubMed ID: 1882876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A team approach to hospital formulary replacement.
    Lee J; Carlson JA; Chamberlain MA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):239-42. PubMed ID: 7587047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulary management.
    Scroccaro G
    Pharmacotherapy; 2000 Oct; 20(10 Pt 2):317S-321S. PubMed ID: 11034059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of anesthetic drugs: experiences with a cost education trial.
    Johnstone RE; Jozefczyk KG
    Anesth Analg; 1994 Apr; 78(4):766-71. PubMed ID: 8135398
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT; Nakagawa RS
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic-interchange program for oral histamine H2-receptor antagonists.
    Chase SL; Peterson AM; Wordell CJ
    Am J Health Syst Pharm; 1998 Jul; 55(13):1382-6. PubMed ID: 9659966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Econotherapeutics.
    Roark MK; Reed WE
    Diagn Microbiol Infect Dis; 1995; 22(1-2):209-17. PubMed ID: 7587042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing prophylactic antibiotic costs in cardiovascular surgery: the role of the clinical pharmacist.
    Peterson CD; Lake KD
    Drug Intell Clin Pharm; 1986 Feb; 20(2):134-7. PubMed ID: 3948689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and cost savings of therapeutic interchange among U.S. hospitals.
    Schachtner JM; Guharoy R; Medicis JJ; Newman N; Speizer R
    Am J Health Syst Pharm; 2002 Mar; 59(6):529-33. PubMed ID: 11908245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost, motion, and time studies comparing a new cephalosporin admixture system.
    Turco SJ
    Hosp Pharm; 1982 Dec; 17(12):653-8. PubMed ID: 10257925
    [No Abstract]   [Full Text] [Related]  

  • 38. Selection of cephalosporins for hospital formularies.
    Wilson WR
    Diagn Microbiol Infect Dis; 1995; 22(1-2):129-34. PubMed ID: 7587026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving patient care and pharmacy management: the effect of hospital formularies.
    Plumridge RJ; Stoelwinder JU; Berbatis CG
    Drug Intell Clin Pharm; 1984; 18(7-8):652-6. PubMed ID: 6430662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in antibiotic costs by restricting use of an oral cephalosporin.
    Seligman SJ
    Am J Med; 1981 Dec; 71(6):941-4. PubMed ID: 7315856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.